RU2018105688A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018105688A3 RU2018105688A3 RU2018105688A RU2018105688A RU2018105688A3 RU 2018105688 A3 RU2018105688 A3 RU 2018105688A3 RU 2018105688 A RU2018105688 A RU 2018105688A RU 2018105688 A RU2018105688 A RU 2018105688A RU 2018105688 A3 RU2018105688 A3 RU 2018105688A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18919108P | 2008-08-15 | 2008-08-15 | |
| US61/189,191 | 2008-08-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013140560A Division RU2646507C2 (ru) | 2008-08-15 | 2013-09-02 | Композиции и способы для лечения во время не острых периодов после неврологического повреждения цнс |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018105688A RU2018105688A (ru) | 2019-08-15 |
| RU2018105688A3 true RU2018105688A3 (ru) | 2021-08-05 |
Family
ID=41669539
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011109546/15A RU2501564C2 (ru) | 2008-08-15 | 2009-08-17 | Композиции и способы для лечения во время не острых периодов после неврологического повреждения цнс |
| RU2013140560A RU2646507C2 (ru) | 2008-08-15 | 2013-09-02 | Композиции и способы для лечения во время не острых периодов после неврологического повреждения цнс |
| RU2018105688A RU2018105688A (ru) | 2008-08-15 | 2018-02-15 | Композиции и способы для лечения во время не острых периодов после неврологического повреждения цнс |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011109546/15A RU2501564C2 (ru) | 2008-08-15 | 2009-08-17 | Композиции и способы для лечения во время не острых периодов после неврологического повреждения цнс |
| RU2013140560A RU2646507C2 (ru) | 2008-08-15 | 2013-09-02 | Композиции и способы для лечения во время не острых периодов после неврологического повреждения цнс |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9498515B2 (ru) |
| EP (3) | EP3173091B1 (ru) |
| CN (3) | CN107041949A (ru) |
| AU (5) | AU2009282455B2 (ru) |
| CA (1) | CA2734766A1 (ru) |
| ES (2) | ES2827923T3 (ru) |
| RU (3) | RU2501564C2 (ru) |
| WO (1) | WO2010019275A2 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107041949A (zh) | 2008-08-15 | 2017-08-15 | 阿索尔达治疗公司 | 在cns神经性损伤后非‑急性期间处理的组合物及方法 |
| WO2011147981A2 (en) * | 2010-05-28 | 2011-12-01 | Mind-Nrg Sa | Neuregulin isoforms, neuregulin polypeptides and uses thereof |
| US20130143805A1 (en) * | 2010-08-13 | 2013-06-06 | Georgetown University | Ggf2 and methods of use |
| US11426447B2 (en) * | 2016-04-19 | 2022-08-30 | Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli) | Neuregulin for the treatment of tumors of the nervous system |
| AR121035A1 (es) | 2019-04-01 | 2022-04-13 | Lilly Co Eli | Compuestos de neuregulina-4 y métodos de uso |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US7285531B1 (en) | 1991-04-10 | 2007-10-23 | Acorda Therapeutics, Inc. | Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor |
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US7094749B1 (en) | 1991-04-10 | 2006-08-22 | Acorda Therapeutics, Inc. | Glial mitogenic factors, their preparation and use |
| US7319019B1 (en) | 1991-04-10 | 2008-01-15 | Acorda Therapeutics, Inc. | Glial mitogenic factors lacking an N-terminal signal sequence |
| GB9107566D0 (en) | 1991-04-10 | 1991-05-29 | Ludwig Inst Cancer Res | Glial mitogenic factors,their preparation and use |
| US7115554B1 (en) | 1993-05-06 | 2006-10-03 | Acorda Therapeutics, Inc. | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| US6087323A (en) | 1992-04-03 | 2000-07-11 | Cambridge Neuroscience, Inc. | Use of neuregulins as modulators of cellular communication |
| US7037888B1 (en) | 1992-04-03 | 2006-05-02 | Acorda Therapeutics, Inc. | Methods for treating muscle diseases and disorders |
| EP0656069A4 (en) | 1992-08-10 | 1996-07-10 | Cambridge Neuroscience Inc | CELL PROLIFERATION INHIBITORS, THEIR PRODUCTION AND USE. |
| GB9217316D0 (en) | 1992-08-14 | 1992-09-30 | Ludwig Inst Cancer Res | Schwann cell mitogenic factor,its preparation and use |
| US6750196B1 (en) | 1995-03-27 | 2004-06-15 | Acorda Therapeutics | Methods of treating disorders of the eye |
| US5912326A (en) | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
| AU745324B2 (en) | 1997-10-14 | 2002-03-21 | Cenes Pharmaceuticals, Inc. | Therapeutic methods comprising use of a neuregulin |
| US6051401A (en) | 1998-07-28 | 2000-04-18 | Bayer Corporation | Methods and constructs for protein expression |
| US6635249B1 (en) | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| ES2370875T3 (es) | 2000-05-23 | 2011-12-23 | Acorda Therapeutics, Inc. | Moléculas de ácido nucleico nrg-2, polipéptidos y métodos de diagnóstico y terapéuticos. |
| US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
| AU2002304965A1 (en) * | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| KR20060002743A (ko) | 2002-12-31 | 2006-01-09 | 악사론 바이오사이언스 아게 | 조혈성장인자에 의한 신경학적 질환의 치료방법 |
| GB0505510D0 (en) * | 2004-06-09 | 2005-04-27 | Univ Edinburgh | Neural stem cells |
| CA2658326C (en) | 2005-09-02 | 2013-04-23 | Morehouse School Of Medicine | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue |
| EP2420565B1 (en) * | 2006-02-23 | 2017-08-30 | ViaCyte, Inc. | Compositions and methods useful for culturing differentiable cells |
| WO2008140814A1 (en) | 2007-05-10 | 2008-11-20 | Acorda Therapeutics, Inc. | Methods for detecting cardiac damage |
| JP5697455B2 (ja) | 2008-02-29 | 2015-04-08 | アコーダ セラピューティクス インコーポレイテッド | グリア成長因子２の所望の血漿レベルを達成するための方法 |
| PL2320933T3 (pl) | 2008-07-17 | 2018-07-31 | Acorda Therapeutics, Inc. | Terapeutyczne dawkowanie neureguliny lub jej subsekwencji do leczenia lub profilaktyki niewydolności serca |
| CN107041949A (zh) | 2008-08-15 | 2017-08-15 | 阿索尔达治疗公司 | 在cns神经性损伤后非‑急性期间处理的组合物及方法 |
-
2009
- 2009-08-17 CN CN201710115521.5A patent/CN107041949A/zh active Pending
- 2009-08-17 WO PCT/US2009/004692 patent/WO2010019275A2/en active Application Filing
- 2009-08-17 CN CN2009801367123A patent/CN102159237A/zh active Pending
- 2009-08-17 RU RU2011109546/15A patent/RU2501564C2/ru active
- 2009-08-17 EP EP16192090.5A patent/EP3173091B1/en active Active
- 2009-08-17 AU AU2009282455A patent/AU2009282455B2/en not_active Ceased
- 2009-08-17 EP EP20179893.1A patent/EP3777878A1/en not_active Withdrawn
- 2009-08-17 US US13/059,206 patent/US9498515B2/en not_active Expired - Fee Related
- 2009-08-17 ES ES16192090T patent/ES2827923T3/es active Active
- 2009-08-17 ES ES09806990.9T patent/ES2609927T3/es active Active
- 2009-08-17 CN CN201410811890.4A patent/CN104707130A/zh active Pending
- 2009-08-17 EP EP09806990.9A patent/EP2328606B1/en not_active Not-in-force
- 2009-08-17 CA CA2734766A patent/CA2734766A1/en not_active Abandoned
-
2013
- 2013-09-02 RU RU2013140560A patent/RU2646507C2/ru active
-
2016
- 2016-08-12 AU AU2016213899A patent/AU2016213899B2/en not_active Ceased
- 2016-11-21 US US15/357,586 patent/US10668131B2/en active Active
-
2018
- 2018-02-15 RU RU2018105688A patent/RU2018105688A/ru unknown
- 2018-03-20 AU AU2018201973A patent/AU2018201973A1/en not_active Abandoned
-
2019
- 2019-12-02 AU AU2019275508A patent/AU2019275508B2/en not_active Ceased
-
2020
- 2020-04-29 US US16/861,330 patent/US20200368318A1/en not_active Abandoned
-
2021
- 2021-11-01 AU AU2021261848A patent/AU2021261848A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2328606A1 (en) | 2011-06-08 |
| AU2019275508B2 (en) | 2021-08-26 |
| EP3173091A1 (en) | 2017-05-31 |
| CN102159237A (zh) | 2011-08-17 |
| AU2018201973A1 (en) | 2018-04-12 |
| CN104707130A (zh) | 2015-06-17 |
| EP2328606B1 (en) | 2016-10-05 |
| US10668131B2 (en) | 2020-06-02 |
| US20110269682A1 (en) | 2011-11-03 |
| RU2018105688A (ru) | 2019-08-15 |
| CN107041949A (zh) | 2017-08-15 |
| EP2328606A4 (en) | 2012-03-14 |
| AU2019275508A1 (en) | 2019-12-19 |
| RU2501564C2 (ru) | 2013-12-20 |
| US20200368318A1 (en) | 2020-11-26 |
| WO2010019275A9 (en) | 2010-05-27 |
| US20170252406A1 (en) | 2017-09-07 |
| RU2013140560A (ru) | 2015-03-10 |
| CA2734766A1 (en) | 2010-02-18 |
| ES2609927T3 (es) | 2017-04-25 |
| AU2009282455B2 (en) | 2016-05-12 |
| AU2016213899A1 (en) | 2016-10-20 |
| AU2021261848A1 (en) | 2021-12-02 |
| WO2010019275A2 (en) | 2010-02-18 |
| EP3777878A1 (en) | 2021-02-17 |
| EP3173091B1 (en) | 2020-07-22 |
| ES2827923T3 (es) | 2021-05-25 |
| RU2011109546A (ru) | 2012-09-20 |
| US9498515B2 (en) | 2016-11-22 |
| RU2646507C2 (ru) | 2018-03-05 |
| AU2016213899B2 (en) | 2018-04-05 |
| AU2009282455A1 (en) | 2010-02-18 |